Browse Data and Analysis

Genetically-engineered (GE) products are highly politicized in Germany. As the EU takes gradual steps towards potentially liberalizing NGTs, German public debate is beginning to shift from a general rejection of GE towards discussion regarding possible liberalization of New Genomic Techniques (NGTs).

Kazakhstan has not announced any changes to its biotechnology policies. Major challenges like climate change, variable weather, monocropping wheat, and the reliance on Eurasian Economic Union (EAEU) member biotechnology regulations could be a future catalyst for Kazakhstan to develop its own biotechnology law.